DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹572 Cr | ₹523 Cr | ₹407 Cr | ₹335 Cr | ₹270 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DIVIS LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹572 Cr |
Mar2023 | ₹523 Cr |
Mar2022 | ₹407 Cr |
Mar2021 | ₹335 Cr |
Mar2020 | ₹270 Cr |
How is Deferred Tax Assets / Liabilities of DIVIS LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹572 Cr | 9.37 | |
Mar2023 | ₹523 Cr | 28.52 | |
Mar2022 | ₹407 Cr | 21.53 | |
Mar2021 | ₹335 Cr | 24.20 | |
Mar2020 | ₹270 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹148,491.5 Cr | 1.9% | 1.5% | 41.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,900.0 Cr | -1.3% | 4.7% | 3.3% | Stock Analytics | |
CIPLA | ₹118,166.0 Cr | 3.4% | 0.1% | -3.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,849.0 Cr | -4.8% | 1.9% | 20.3% | Stock Analytics | |
MANKIND PHARMA | ₹97,009.6 Cr | -4% | 4% | -1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,553.6 Cr | -0.1% | -1% | -11.3% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1.9% |
1.5% |
41.9% |
SENSEX | -1.5% |
1.1% |
1.2% |
You may also like the below Video Courses